康達爾(000048.SZ)收到寶安管理局下發的兩宗地閒置處置方案告知書
格隆匯12月24日丨康達爾(000048.SZ)公佈,公司於2019年6月11日收到深圳市規劃和自然資源局寶安管理局(“寶安管理局”)下發的關於A108-1159宗地、A108-1160宗地閒置土地認定書(深規劃資源寶函[2019]514號、520號)和閒置土地處置聽證權利告知書(深規劃資源寶函[2019]517號、519號)。
2019年12月23日,公司收到寶安管理局下發的關於上述兩宗地閒置處置方案告知書(深規劃資源寶函[2019]1457號、1458號),確定該兩宗地閒置處置方案為:延長動工開發期限。公司可在收到該告知書之日起10日內到寶安管理局申請辦理有關用地手續。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.